Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351477	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0"	"Cell type enriched"	"Detected in many"	10	"Late spermatids: 3052.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	84	"Leukemia: 30.1;lymphoma: 34.7;Myeloma: 16.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075570	Approved		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 2: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 51: Late spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favorable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"
ANO9	"PIG5, TMEM16J, TP53I5"	ENSG00000185101	"Anoctamin 9"	A1A5B4	11	417933-442011	"Predicted membrane proteins, Transporters"	"Lipid metabolism, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.2;skin 1: 27.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 59.6;Intestinal goblet cells: 47.4;Paneth cells: 31.7;Proximal enterocytes: 76.3;Undifferentiated cells: 38.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 26.1"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	48	"B-cells: 2.1;NK-cells: 4.1;T-cells: 8.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 17.3"	"Adipose subcutaneous - T-cells, Liver - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039948, HPA040112"	Approved		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 26: Intestinal epithelial cells - Absorption"	"Golgi apparatus"		"HPA039948: AB_2676765, HPA040112: "	"unprognostic (3.62e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.98e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (8.81e-4)"
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039233-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.3;B-cells: 23.6;Endothelial cells: 22.8;Kupffer cells: 18.4;NK-cells: 41.6;T-cells: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5"	"Group enriched"	"Detected in all"	6	"B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3"	"Cancer enhanced"	"Detected in many"		"Leukemia: 26.5"	"Colon - Endothelial cells, Liver - T-cells, Thyroid - T-cells"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"
APOBEC3D	"APOBEC3DE, APOBEC3E, ARP6"	ENSG00000243811	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3D"	Q96AK3	22	39021113-39033277	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.7;Microglial cells: 2.7;NK-cells: 2.9;Plasma cells: 4.6;Sertoli cells: 2.8;T-cells: 4.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Myeloma: 11.6"	"Breast - T-cells, Liver - T-cells, Thyroid - T-cells"									HPA055116	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"			"HPA055116: AB_2682701"	"prognostic favorable (2.51e-5)"	"prognostic favorable (1.31e-4)"	"unprognostic (2.69e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (3.76e-7)"	"unprognostic (4.76e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (3.01e-4)"
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 68.3;intestine: 53.2;lung: 39.5;lymphoid tissue: 106.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 74.4;Kupffer cells: 76.7;monocytes: 87.2;NK-cells: 81.1;Syncytiotrophoblasts: 74.6;T-cells: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 92.8;lymphoma: 78.9;Myeloma: 97.0"	"Colon - T-cells, Liver - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019816, HPA079252"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA019816: AB_1853923, HPA079252: "	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 101.5;salivary gland: 185.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 78.8;dendritic cells: 72.1;Distal enterocytes: 108.8;Enteroendocrine cells: 74.9;Gastric mucus-secreting cells: 119.2;Intestinal goblet cells: 130.5;Plasma cells: 86.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 129.6;lymphoma: 112.9"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - T-cells, Liver - T-cells, Skin - Eccrine sweat gland cells, Stomach - Gastric mucous cells"	"Region enriched"	"Detected in all"	15	"cerebellum: 67.2"	"Low region specificity"	"Detected in all"			"HPA007180, CAB010882"	Approved					NA	NA		5400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"
CD19		ENSG00000177455	"CD19 molecule"	P15391	16	28931965-28939342	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 33.0;lymphoid tissue: 75.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 130.2;Early spermatids: 49.1;Plasma cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	80	"memory B-cell: 138.2;naive B-cell: 172.1"	"Lineage enriched"	"Detected in many"	89	"B-cells: 172.1"	"Group enriched"	"Detected in some"	13	"Leukemia: 36.7;lymphoma: 69.1"	"Liver - T-cells, Lung - B-cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB016110	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB016110: AB_626952"	"unprognostic (3.27e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.11e-5)"	"unprognostic (2.61e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.29e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-1)"
CD1C	CD1	ENSG00000158481	"CD1c molecule"	P29017	1	158289923-158294774	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 130.4"	"Cell type enriched"	"Detected in some"	10	"Langerhans cells: 750.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 84.1;myeloid DC: 324.9"	"Group enriched"	"Detected in many"	8	"B-cells: 84.1;dendritic cells: 324.9"	"Group enriched"	"Detected in some"	34	"Leukemia: 5.0;lymphoma: 4.6"	"Liver - T-cells, Skin - Langerhans cells, Thyroid - T-cells"									HPA068359			Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA		200000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 75: Myeloid cells - Innate immune response"	"Golgi apparatus, Vesicles"	"Endoplasmic reticulum"	"HPA068359: "	"unprognostic (2.55e-3)"	"prognostic favorable (1.79e-5)"	"unprognostic (1.75e-5)"	"unprognostic (3.09e-5)"	"unprognostic (3.12e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.80e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.99e-1)"
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648158-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 15.5"	"Cell type enriched"	"Detected in some"	9	"T-cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 26.3;MAIT T-cell: 64.1;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.1"	"Lineage enriched"	"Detected in many"	39	"T-cells: 80.5"	"Cancer enriched"	"Detected in single"	14	"Leukemia: 2.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045827, HPA072480"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA	776000	20000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Golgi apparatus, Plasma membrane"		"HPA045827: AB_10959606, HPA072480: "	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"
CD5	"LEU1, T1"	ENSG00000110448	"CD5 molecule"	P06127	11	61102489-61127852	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.5"	"Cell type enriched"	"Detected in some"	4	"T-cells: 56.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 138.2"	"Lineage enriched"	"Detected in many"	33	"T-cells: 138.2"	"Group enriched"	"Detected in some"	9	"Leukemia: 17.2;lymphoma: 28.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB015392, CAB020308, HPA043416, HPA060839"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376"	"prognostic favorable (4.05e-4)"	"prognostic favorable (9.16e-5)"	"unprognostic (2.33e-1)"	"prognostic favorable (9.00e-5)"	"unprognostic (1.02e-2)"	"prognostic favorable (7.41e-6)"	"unprognostic (2.45e-3)"	"unprognostic (1.37e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.94e-5)"	"unprognostic (4.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.06e-1)"
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 369.0"	"Cell type enriched"	"Detected in many"	4	"T-cells: 231.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"MAIT T-cell: 234.4;memory CD8 T-cell: 523.0;naive CD8 T-cell: 476.8"	"Lineage enriched"	"Detected in many"	19	"T-cells: 523.0"	"Group enriched"	"Detected in some"	8	"Leukemia: 6.0;lymphoma: 10.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648"	"unprognostic (1.29e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favorable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 459.6"	"Cell type enriched"	"Detected in many"	6	"T-cells: 154.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"memory CD8 T-cell: 601.8;naive CD8 T-cell: 1053.9"	"Lineage enriched"	"Detected in all"	25	"T-cells: 1053.9"	"Group enriched"	"Detected in some"	8	"Leukemia: 8.8;Myeloma: 33.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favorable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"
CD96	TACTILE	ENSG00000153283	"CD96 molecule"	P40200	3	111292719-111665750	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.8"	"Group enriched"	"Detected in many"	6	"NK-cells: 121.7;T-cells: 195.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 74.0;MAIT T-cell: 117.2;memory CD4 T-cell: 67.0;memory CD8 T-cell: 85.3;naive CD4 T-cell: 68.7;naive CD8 T-cell: 81.8;NK-cell: 79.5;T-reg: 47.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 79.5;T-cells: 117.2"	"Cancer enhanced"	"Detected in many"		"Leukemia: 31.4;skin cancer: 16.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066754	Enhanced					NA	NA		85000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"HPA066754: AB_2685714"	"unprognostic (1.06e-3)"	"unprognostic (3.95e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.91e-5)"	"unprognostic (4.72e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.06e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (5.23e-5)"
CLEC2D	"CLAX, LLT1, OCIL"	ENSG00000069493	"C-type lectin domain family 2 member D"	Q9UHP7	12	9664969-9699553	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.6;Early spermatids: 79.1;NK-cells: 136.3;T-cells: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"gdT-cell: 188.1;MAIT T-cell: 114.5;memory B-cell: 95.0;memory CD4 T-cell: 183.3;memory CD8 T-cell: 208.7;naive B-cell: 127.5;naive CD4 T-cell: 192.3;naive CD8 T-cell: 223.0;T-reg: 175.2"	"Group enriched"	"Detected in all"	11	"B-cells: 127.5;T-cells: 223.0"	"Group enriched"	"Detected in all"	4	"Leukemia: 18.0;lymphoma: 53.3;Myeloma: 16.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Liver - T-cells, Thyroid - T-cells"									"HPA017649, HPA047584"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Golgi apparatus"		"HPA017649: AB_1846912, HPA047584: "	"unprognostic (1.09e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.85e-11)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.68e-7)"
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872643	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 14.2;Macrophages: 10.9;monocytes: 13.5;NK-cells: 55.4;T-cells: 50.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 54.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 54.0;T-cells: 33.3"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Liver - T-cells, Prostate - T-cells"	"Region enriched"	"Detected in some"	44	"cerebellum: 102.6"	"Region enriched"	"Detected in all"	7	"cerebellum: 25.7"							NA	NA		6800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"
CXCR3	"CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR"	ENSG00000186810	"C-X-C motif chemokine receptor 3"	P49682	X	71615916-71618511	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;intestine: 6.4;lymphoid tissue: 16.3"	"Cell type enriched"	"Detected in some"	8	"dendritic cells: 385.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 306.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 306.7;NK-cells: 198.9;T-cells: 124.7"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 1.6;Leukemia: 1.5;lymphoma: 5.9;Myeloma: 4.3"	"Adipose subcutaneous - T-cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045942	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 48: Plasmacytoid dendritic cells - Unknown function"			"HPA045942: AB_2679507"	"unprognostic (4.84e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.61e-1)"	"prognostic favorable (3.44e-6)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.01e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.67e-6)"	"unprognostic (4.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.76e-2)"
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 91.2;Late spermatids: 146.4;NK-cells: 73.5;T-cells: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 75.5;Myeloma: 54.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Skin - Keratinocyte (other), Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 2: T-cells - T-cell receptor"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 73.9"	"Group enriched"	"Detected in many"	4	"monocytes: 38.2;NK-cells: 74.0;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 243.8"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 11.7;lymphoma: 11.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Spermatogonia, Thyroid - T-cells"	"Low region specificity"	"Detected in many"							HPA028656	Supported					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"			"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92473043-92486925	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 53.7;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in some"		"granulocytes: 5.1;Intestinal goblet cells: 16.9;NK-cells: 16.2;Plasma cells: 7.6;T-cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cancer enriched"	"Detected in many"	5	"Leukemia: 62.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favorable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"
GPR171	H963	ENSG00000174946	"G protein-coupled receptor 171"	O14626	3	151197832-151203216	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.3"	"Cell type enriched"	"Detected in some"	4	"T-cells: 119.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 110.3"	"Lineage enriched"	"Detected in many"	15	"T-cells: 110.3"	"Group enriched"	"Detected in some"	43	"Leukemia: 2.3;lymphoma: 7.6;Myeloma: 2.8"	"Kidney - T-cells, Liver - T-cells, Prostate - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067323	Supported					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"HPA067323: "	"unprognostic (6.82e-6)"	"unprognostic (4.90e-3)"	"unprognostic (7.10e-2)"	"unprognostic (6.85e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.04e-3)"	"unprognostic (4.19e-4)"	"unprognostic (6.09e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"
GZMK	"PRSS, TRYP2"	ENSG00000113088	"Granzyme K"	P49863	5	55024256-55034570	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 99.6"	"Group enriched"	"Detected in many"	6	"NK-cells: 135.1;T-cells: 259.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 741.6;NK-cell: 505.5"	"Group enriched"	"Detected in many"	199	"NK-cells: 505.5;T-cells: 741.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA063181, HPA065895"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"HPA063181: AB_2684955, HPA065895: "	"prognostic favorable (8.68e-4)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.03e-3)"	"unprognostic (8.13e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936763-203961577	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 16.5;lymphoid tissue: 20.2"	"Cell type enriched"	"Detected in some"	10	"T-cells: 89.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 29.1"	"Lineage enriched"	"Detected in single"	54	"T-cells: 29.1"	"Cancer enhanced"	"Detected in some"		"Leukemia: 2.4;lymphoma: 3.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Spermatogonia, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 118.0;lymphoid tissue: 346.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 112.9;dendritic cells: 93.7;Distal enterocytes: 87.2;Langerhans cells: 151.6;NK-cells: 284.8;Plasma cells: 91.0;Proximal enterocytes: 80.8;T-cells: 197.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Leukemia: 203.1;lymphoma: 129.5;Myeloma: 347.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"									HPA046641	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA		13000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Nucleoplasm, Plasma membrane"	"Endoplasmic reticulum"	"HPA046641: AB_2679733"	"unprognostic (2.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (8.25e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.28e-7)"	"unprognostic (1.73e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.54e-2)"
ITGAL	"CD11A, LFA-1"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 43.6;monocytes: 151.0;NK-cells: 195.1;T-cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 121.7"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	125	"Leukemia: 74.5;lymphoma: 40.6;Myeloma: 51.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced					NA	NA		1600000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB025011: "	"unprognostic (1.10e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.72e-3)"	"prognostic favorable (5.63e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (5.57e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-2)"
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255185	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 57.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 29.4;NK-cells: 75.1;Serous glandular cells: 22.9;T-cells: 127.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	23	"gdT-cell: 39.6;MAIT T-cell: 26.4;memory CD4 T-cell: 55.6;memory CD8 T-cell: 54.9;naive CD4 T-cell: 78.2;naive CD8 T-cell: 65.0;NK-cell: 29.3;T-reg: 73.2"	"Group enriched"	"Detected in many"	23	"NK-cells: 29.3;T-cells: 78.2"	"Group enriched"	"Detected in some"	44	"Leukemia: 7.3;lymphoma: 5.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043670			Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA043670: "	"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"
ITPRIPL1	KIAA1754L	ENSG00000198885	"ITPRIP like 1"	Q6GPH6	2	96325317-96330517	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 152.7;Late spermatids: 168.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 12.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 12.9"	"Cancer enhanced"	"Detected in many"		"lymphoma: 25.3"	"Adipose subcutaneous - Endothelial cells, Colon - Endothelial cells, Liver - T-cells, Prostate - Prostate basal glandular cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 1: T-cells - Immune response"				"unprognostic (1.26e-3)"	"unprognostic (3.56e-3)"	"unprognostic (4.78e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.56e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.41e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.39e-2)"
JAKMIP1	"FLJ31564, Gababrbp, JAMIP1, MARLIN1"	ENSG00000152969	"Janus kinase and microtubule interacting protein 1"	Q96N16	4	6026199-6200591	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.1;pituitary gland: 10.2;retina: 17.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 34.5;Excitatory neurons: 81.7;Inhibitory neurons: 52.3;Muller glia cells: 42.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"gdT-cell: 25.3;MAIT T-cell: 11.2;memory CD4 T-cell: 11.2;memory CD8 T-cell: 22.6;naive CD8 T-cell: 10.1;T-reg: 36.7"	"Lineage enriched"	"Detected in many"	33	"T-cells: 36.7"	"Cancer enhanced"	"Detected in some"		"lymphoma: 12.6;Myeloma: 9.6;Neuroblastoma: 8.2"	"Adipose subcutaneous - T-cells, Colon - Colon enteroendocrine cells, Liver - T-cells, Pancreas - Beta cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044570	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 38: Neurons - Neuronal signaling"			"HPA044570: AB_2678995"	"unprognostic (4.79e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.86e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.25e-4)"	"unprognostic (7.14e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-8)"	"unprognostic (1.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.96e-3)"
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 349.2"	"Group enriched"	"Detected in many"	4	"Melanocytes: 47.0;Microglial cells: 141.4;T-cells: 77.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 142.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 142.6"	"Cancer enhanced"	"Detected in many"		"Leukemia: 150.9"	"Liver - T-cells, Skin - Inner root sheath cells, Testis - Early spermatids"	"Region enhanced"	"Detected in all"		"thalamus: 22.6"	"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favorable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 66.7;lymphoid tissue: 229.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 1093.3;dendritic cells: 320.2;Ductal cells: 270.7;Exocrine glandular cells: 811.3;T-cells: 571.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 28.4;lymphoma: 55.6"	"Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Prostate - T-cells, Skin - Langerhans cells, Thyroid - T-cells"	"Not detected"	"Not detected"							HPA048884	Approved		Approved	Centrosome		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Centrosome		"HPA048884: AB_2680543"	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favorable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 245.9;dendritic cells: 62.8;Langerhans cells: 37.8;Plasma cells: 72.1;T-cells: 45.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"lymphoma: 12.3;Myeloma: 38.9"	"Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Pancreas - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050917	Approved		Approved	"Plasma membrane,Centriolar satellite"		NA	NA		43000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"	"Centriolar satellite"	"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.5;lymphoid tissue: 13.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 10.6;Erythroid cells: 10.5;NK-cells: 32.2;T-cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Leukemia: 10.5;lymphoma: 13.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"
PATL2	Pat1a	ENSG00000229474	"PAT1 homolog 2"	C9JE40	15	44665732-44711316	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.7;lymphoid tissue: 17.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 29.8;Cardiomyocytes: 22.4;NK-cells: 39.6;T-cells: 27.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 21.6;memory CD4 T-cell: 6.0;memory CD8 T-cell: 17.7;naive CD8 T-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 21.6"	"Cancer enhanced"	"Detected in some"		"lymphoma: 6.4;Myeloma: 12.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"													NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 50: L-1236 & L-428 - Unknown function"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (1.28e-2)"	"unprognostic (8.59e-3)"	"unprognostic (3.30e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-4)"
PDCD1	"CD279, hSLE1, PD-1, PD1, SLEB2"	ENSG00000188389	"Programmed cell death 1"	Q15116	2	241849884-241858894	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"		"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 6.7;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"Schwann cells: 8.3;T-cells: 30.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Group enriched"	"Detected in many"	5	"gdT-cell: 4.4;MAIT T-cell: 4.8;memory CD4 T-cell: 8.7;memory CD8 T-cell: 12.4;T-reg: 4.3"	"Lineage enriched"	"Detected in single"	55	"T-cells: 12.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.0;lymphoma: 1.4"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035981, CAB038418, CAB076386"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: DU4475 - Unknown function"	"Cluster 1: T-cells - Immune response"			"CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664"	"unprognostic (2.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (7.78e-2)"	"prognostic favorable (9.44e-5)"	"unprognostic (7.18e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.82e-3)"	"unprognostic (3.75e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (5.06e-3)"
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 33.6;skeletal muscle: 124.5;tongue: 112.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.1;NK-cells: 34.2;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 71.0;Skeletal myocytes: 34.6;T-cells: 35.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.0;MAIT T-cell: 18.0;memory CD4 T-cell: 24.5;memory CD8 T-cell: 24.5;naive CD4 T-cell: 19.1;naive CD8 T-cell: 17.9;NK-cell: 13.3;T-reg: 39.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 13.3;T-cells: 39.7"	"Cancer enriched"	"Detected in many"	5	"Leukemia: 17.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - T-cells, Lung - Alveolar cells type 2, Prostate - T-cells, Skeletal muscle - Skeletal myocytes, Skin - T-cells, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 1: T-cells - Immune response"	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (3.51e-2)"
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 56.6;lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 54.7;Kupffer cells: 54.0;Langerhans cells: 38.0;Macrophages: 41.3;monocytes: 32.9;NK-cells: 72.7;T-cells: 64.7;Theca cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Leukemia: 13.3;lymphoma: 11.8"	"Adipose subcutaneous - Macrophages, Heart muscle - Macrophages, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010116, HPA010600, HPA072744"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA010116: , HPA010600: AB_1855870, HPA072744: "	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favorable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity, Lipid metabolism"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 57.0;granulocytes: 38.6;NK-cells: 204.4;T-cells: 143.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Leukemia: 15.4;lymphoma: 22.3;Myeloma: 12.6"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 43.8;granulocytes: 71.9;NK-cells: 133.5;T-cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Group enriched"	"Detected in some"	41	"Leukemia: 72.3;lymphoma: 27.8;Myeloma: 22.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Prostate - T-cells, Testis - Sertoli cells, Thyroid - T-cells"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"
RHOH	"ARHH, TTF"	ENSG00000168421	"Ras homolog family member H"	Q15669	4	40191053-40246967	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.9;lymphoid tissue: 98.2"	"Group enriched"	"Detected in many"	6	"B-cells: 234.2;granulocytes: 305.0;NK-cells: 110.3;Plasma cells: 137.4;T-cells: 216.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Bone cancer: 37.0;Leukemia: 54.2;lymphoma: 77.1;Myeloma: 49.0"	"Adipose visceral - T-cells, Liver - T-cells, Prostate - T-cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030345, HPA061314"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA030345: AB_10601607, HPA061314: "	"unprognostic (4.00e-2)"	"unprognostic (1.83e-4)"	"unprognostic (1.24e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.31e-6)"	"unprognostic (2.96e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.44e-2)"
SHISAL2A	"FAM159A, MGC52498"	ENSG00000182183	"Shisa like 2A"	Q6UWV7	1	52633168-52669683	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;intestine: 3.7;lymphoid tissue: 5.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.5;NK-cells: 20.2;Plasma cells: 9.2;T-cells: 20.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.7"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 10.1;NK-cells: 5.9;T-cells: 7.0"	"Group enriched"	"Detected in some"	9	"Leukemia: 1.3;lymphoma: 3.3;Myeloma: 4.2"	"Adipose visceral - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.0"	"Low region specificity"	"Detected in some"			HPA030744	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA030744: AB_10963060"	"unprognostic (7.94e-6)"	"unprognostic (8.50e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.64e-2)"
SIRPG	"bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma"	ENSG00000089012	"Signal regulatory protein gamma"	Q9P1W8	20	1629152-1657779	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 39.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 63.4;T-cells: 39.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 369.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 369.4"	"Cancer enhanced"	"Detected in some"		"Leukemia: 2.3;ovarian cancer: 2.2;thyroid cancer: 4.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Early spermatids, Testis - Late spermatids"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (3.35e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.23e-3)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (7.36e-7)"	"unprognostic (1.62e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.95e-3)"
SLAMF1	"CD150, SLAM"	ENSG00000117090	"Signaling lymphocytic activation molecule family member 1"	Q13291	1	160608106-160647295	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 76.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 25.6;Langerhans cells: 10.1;Plasma cells: 41.1;T-cells: 38.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 66.3"	"Group enriched"	"Detected in many"	10	"B-cells: 22.7;T-cells: 66.3"	"Cancer enhanced"	"Detected in some"		"Leukemia: 13.5;lymphoma: 38.5"	"Adipose subcutaneous - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002438, HPA069319"	Enhanced				"Secreted to blood"	NA	NA		350000	"Cluster 13: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 1: T-cells - Immune response"			"CAB002438: AB_564011, HPA069319: AB_2732129"	"unprognostic (2.99e-3)"	"unprognostic (3.33e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.38e-4)"	"unprognostic (5.87e-2)"	"unprognostic (6.06e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.74e-4)"	"unprognostic (6.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-7)"	"unprognostic (2.46e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-2)"
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 61.7"	"Group enriched"	"Detected in some"	5	"B-cells: 22.0;Late spermatids: 23.2;NK-cells: 39.8;Plasma cells: 18.2;Serous glandular cells: 12.7;T-cells: 34.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Leukemia: 9.2;lymphoma: 34.1"	"Breast - Plasma cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA051363: AB_2681454, HPA051903: AB_2681658"	"prognostic favorable (9.42e-4)"	"prognostic favorable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favorable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favorable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"
SLAMF7	"19A, CD319, CRACC, CS1"	ENSG00000026751	"SLAM family member 7"	Q9NQ25	1	160739057-160754821	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6;lymphoid tissue: 62.0;stomach 1: 34.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 80.9;monocytes: 44.3;NK-cells: 64.1;Plasma cells: 243.3;Schwann cells: 66.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	7	"Myeloma: 184.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Liver - T-cells, Lung - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015445, HPA055945, HPA061654"	Enhanced		Approved	Vesicles		NA	NA		1200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 40: Plasma cells - Humoral immune response"	Vesicles		"CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.46e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.57e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-2)"
SP140	"LYSP100-A, LYSP100-B"	ENSG00000079263	"SP140 nuclear body protein"	Q13342	2	230203110-230313215	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 15.6;lymphoid tissue: 55.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 148.0;monocytes: 37.4;NK-cells: 61.8;Plasma cells: 81.0;T-cells: 56.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 97.5"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"lymphoma: 41.9;Myeloma: 17.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Prostate - T-cells, Testis - Early spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"							"HPA006162, HPA067493"	Enhanced		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoli fibrillar center"	Mitochondria	"HPA006162: AB_1857403, HPA067493: AB_2685851"	"unprognostic (8.15e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-3)"	"unprognostic (5.72e-4)"	"unprognostic (5.66e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.20e-9)"	"unprognostic (9.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.30e-3)"
SPOCK2	"KIAA0275, testican-2"	ENSG00000107742	"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2"	Q92563	10	72059034-72089032	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 220.1;lymphoid tissue: 114.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 630.3;Bipolar cells: 106.6;Horizontal cells: 105.7;NK-cells: 132.1;Sertoli cells: 152.0;T-cells: 203.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 117.5;MAIT T-cell: 198.8;memory CD4 T-cell: 115.9;memory CD8 T-cell: 93.5;naive CD4 T-cell: 87.8;naive CD8 T-cell: 89.4;T-reg: 174.3"	"Lineage enriched"	"Detected in all"	8	"T-cells: 198.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 156.1;Uterine cancer: 97.0"	"Colon - Colon enteroendocrine cells, Kidney - Podocytes, Liver - T-cells, Lung - Alveolar cells type 1, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044605	Enhanced				"Secreted to blood"	NA	NA		34000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 1: T-cells - Immune response"			"HPA044605: AB_10965991"	"prognostic favorable (4.05e-4)"	"unprognostic (3.11e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.18e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (4.72e-4)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (4.53e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.24e-2)"
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;pancreas: 106.3;skin 1: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 159.5;NK-cells: 150.6;Squamous epithelial cells: 181.7;Suprabasal keratinocytes: 151.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 4.3;cerebellum: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 62.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Skin - Keratinocyte (other), Thyroid - T-cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 22: Squamous epithelial cells - Keratinization"			"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 32.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 46.3;Microglial cells: 14.6;Serous glandular cells: 10.9;T-cells: 66.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	22	"gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3"	"Lineage enriched"	"Detected in single"	88	"T-cells: 58.3"	"Group enriched"	"Detected in some"	19	"Leukemia: 3.6;lymphoma: 3.1;Myeloma: 5.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 52.0;granulocytes: 30.8;Hofbauer cells: 31.4;Langerhans cells: 43.5;monocytes: 38.7;NK-cells: 66.1;T-cells: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Leukemia: 67.0;lymphoma: 48.3;Myeloma: 71.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822770-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 79.8"	"Cell type enriched"	"Detected in some"	11	"T-cells: 118.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 395.1"	"Group enriched"	"Detected in many"	155	"granulocytes: 395.1;T-cells: 313.1"	"Cancer enhanced"	"Detected in some"		"Leukemia: 10.2;lymphoma: 2.5;Myeloma: 2.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Liver - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"
TRBC1	"BV05S1J2.2, TCRBC1"	ENSG00000211751	"T cell receptor beta constant 1"		7	142791694-142793368	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	28	"lymphoid tissue: 1520.1"	"Group enriched"	"Detected in many"	17	"NK-cells: 443.4;T-cells: 435.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 3232.4"	"Lineage enriched"	"Detected in all"	9	"T-cells: 3232.4"	"Cancer enriched"	"Detected in some"	6	"Leukemia: 98.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (1.08e-4)"	"unprognostic (7.96e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.81e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.76e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.36e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.18e-6)"	"unprognostic (3.98e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.19e-3)"
TRBV27	"TCRBV14S1, TCRBV27S1"	ENSG00000211752	"T cell receptor beta variable 27"	A0A0K0K1C4	7	142715346-142715861	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 81.6"	"Group enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 1.8;T-cells: 5.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 61.1;memory CD8 T-cell: 112.2;naive CD4 T-cell: 48.2;naive CD8 T-cell: 75.8;T-reg: 94.7"	"Lineage enriched"	"Detected in single"	137	"T-cells: 112.2"	"Cancer enriched"	"Detected in single"	5	"Leukemia: 3.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"					"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (3.08e-2)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-2)"			"unprognostic (5.85e-4)"	"unprognostic (8.84e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.91e-7)"	"unprognostic (4.03e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.43e-2)"
TRGC2	"TCRGC2, TRGC2(2X), TRGC2(3X)"	ENSG00000227191	"T cell receptor gamma constant 2"		7	38239580-38249572	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 30.5;lymphoid tissue: 34.6;prostate: 23.7"	"Group enriched"	"Detected in some"	4	"NK-cells: 84.0;T-cells: 110.9"	"Cancer enriched"	"Detected in many"	18	"prostate cancer: 26.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 720.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 720.5"	"Group enriched"	"Detected in some"	23	"Leukemia: 42.6;prostate cancer: 13.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - Prostate glandular cells, Skin - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (2.79e-3)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.62e-4)"	"unprognostic (3.52e-5)"	"unprognostic (3.34e-1)"	"unprognostic (1.46e-3)"	"unprognostic (8.79e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-3)"
TTC16	FLJ32780	ENSG00000167094	"Tetratricopeptide repeat domain 16"	Q8NEE8	9	127716079-127731590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"fallopian tube: 6.9;testis: 16.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 91.0;Late spermatids: 259.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - T-cells, Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 6: Late spermatids - Spermatogenesis"				"unprognostic (3.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-4)"	"unprognostic (4.08e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.87e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.35e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.54e-3)"
ZNF831	"C20orf174, dJ492J12.1"	ENSG00000124203	"Zinc finger protein 831"	Q5JPB2	20	59123381-59259113	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lymphoid tissue: 6.2"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 19.3;NK-cells: 29.9;T-cells: 53.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 1.2;T-cells: 2.1"	"Cancer enhanced"	"Detected in single"		"Rhabdoid: 2.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	25	"amygdala: 4.6;basal ganglia: 4.1;cerebral cortex: 3.4;hippocampal formation: 5.0;olfactory bulb: 5.4"	HPA016839	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 1: T-cells - Immune response"			"HPA016839: AB_1859466"	"unprognostic (2.90e-3)"	"unprognostic (7.70e-6)"	"unprognostic (9.71e-4)"	"unprognostic (1.31e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.00e-5)"	"unprognostic (3.08e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.31e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.93e-2)"